GU CONNECT is an international group of experts in the field of genitourinary oncology and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the GU CONNECT experts

What’s new from GU CONNECT

conference-update Conference update
Oncology 
ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2024

interactive-patient-case Interactive patient case
Oncology 
Advanced renal cell carcinoma: Managing a long-term durable response

Maximising outcomes for patients with advanced RCC 

Experts
Prof. Michael Staehler
Endorsed by
Urobel VZW | ASBL EAUN
  • clock MIN
  • calendar Jun 2024

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited.
conference-update Conference update
Oncology 
RCC Update from ESMO 2023

How will the latest data impact clinical practice?

Experts
Prof. Laurence Albiges
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited.
micro-learning Micro learning

Module

2

of 2

module
Oncology 
PARP inhibitors in prostate cancer and the rationale behind combination treatment

Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens

Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale Rescigno
Endorsed by
ZERO EAUN
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
interactive-patient-case Interactive patient case
Oncology 
Optimising treatment for advanced RCC

Journey through an interactive patient case

Experts
Prof. Viktor Grünwald
  • clock 15 MIN
  • calendar Oct 2023

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited.
video Video

Episode

2

of 2

episode
Oncology 
Clinical implementation of testing and PARPis in combination with NHAs

Episode 2: Clinical implementation of testing and PARP inhibitors in combination with NHAs

Experts
Dr Andrew J. Armstrong
Endorsed by
ZERO NASPCC
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jul 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca